Plasma levels of substance P, neuropeptide Y and vasoactive intestinal polypeptide in patients with chronic tension-type headache

被引:35
作者
Ashina, M [1 ]
Bendtsen, L
Jensen, R
Ekman, R
Olesen, J
机构
[1] Univ Copenhagen, Glostrup Hosp, Dept Neurol, DK-2600 Glostrup, Denmark
[2] Univ Gothenburg, Dept Psychiat & Neurochem, Mondal Hosp, S-41180 Molndal, Sweden
关键词
substance P; neuropeptide Y; vasoactive intestinal polypeptide; tension-type headache;
D O I
10.1016/S0304-3959(99)00159-1
中图分类号
R614 [麻醉学];
学科分类号
100217 [麻醉学];
摘要
Animal and human studies have shown that substance P (SP), neuropeptide Y (NPY) and vasoactive intestinal polypeptide (VIP) are involved in the pathophysiology of acute and chronic pain conditions. The primary aim of the present study was to compare plasma levels of SP, NPY and VIP in external jugular vein between patients with chronic tension-type headache and healthy controls. The secondary aim was to examine plasma levels of these neuropeptides in relation to headache state. In addition, we wanted to study the relation between cranial circulation (jugular vein) and peripheral circulation (antecubital vein). Blood from the external jugular and antecubital vein was drawn from 20 patients with chronic tension-type headache and 20 healthy controls. Plasma SP in patients, 2.0 (1.4-2.2) pmol/l, did not differ significantly from plasma SP in controls, 1.7 (1.1-2.1) pmol/l, (P = 0.44). No significant differences were found between SP levels on days with headache, 1.5 (0.3-1.7) pmol/l, and SP levels on days without headache, 1.7 (1.1-1.9) pmol/l, (P = 0.06). Plasma NPY in patients, 118 +/- 3 pmol/l, did not differ significantly from plasma NPY in controls, 113 +/- 5 pmol/l, (P = 0.40). There was no difference between NPY levels on days with headache, 120 +/- 3 pmol/l, and on days without headache, 118 +/- 3 pmol/l, (P = 0.73). VIP levels in patients, 6 (4-7) pmol/l, did not differ significantly from VIP levels in controls, 5 (5-7) pmol/l, (P = 0.50). No significant differences were found between VIP levels measured on days with headache, 5 (4-6) pmol/l, and VIP levels measured on days without headache, 6 (4-7) pmol/l, (P = 0.81). Plasma levels of SP, NPY and VIP did not significantly differ between the peripheral and the cranial circulation neither in patients nor in controls (P > 0.05). In summary, the present study indicates that plasma levels of SP, NPY and VIP are normal in chronic tension-type headache patients and largely unrelated to headache state. (C) 1999 International Association for the Study of Pain. Published by Elsevier Science B.V.
引用
收藏
页码:541 / 547
页数:7
相关论文
共 36 条
[1]
Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial [J].
Ashina, M ;
Lassen, LH ;
Bendtsen, L ;
Jensen, R ;
Olesen, J .
LANCET, 1999, 353 (9149) :287-289
[2]
Qualitatively altered nociception in chronic myofascial pain [J].
Bendtsen, L ;
Jensen, R ;
Olesen, J .
PAIN, 1996, 65 (2-3) :259-264
[3]
Doyle CA, 1997, PROG PAIN RES MANAG, V9, P145
[4]
MICROINJECTION OF NEUROPEPTIDE-Y INTO THE SUPERFICIAL DORSAL HORN REDUCES STIMULUS-EVOKED RELEASE OF IMMUNOREACTIVE SUBSTANCE-P IN THE ANESTHETIZED CAT [J].
DUGGAN, AW ;
HOPE, PJ ;
LANG, CW .
NEUROSCIENCE, 1991, 44 (03) :733-740
[5]
VASOACTIVE PEPTIDE LEVELS IN THE PLASMA OF YOUNG MIGRAINE PATIENTS WITH AND WITHOUT AURA ASSESSED BOTH INTERICTALLY AND ICTALLY [J].
GALLAI, V ;
SARCHIELLI, P ;
FLORIDI, A ;
FRANCESCHINI, M ;
CODINI, M ;
GLIOTI, G ;
TREQUATTRINI, A ;
PALUMBO, R .
CEPHALALGIA, 1995, 15 (05) :384-390
[6]
NEUROPEPTIDE-Y IN JUVENILE MIGRAINE AND TENSION-TYPE HEADACHE [J].
GALLAI, V ;
SARCHIELLI, P ;
TREQUATTRINI, A ;
PACIARONI, M ;
USAI, F ;
PALUMBO, R .
HEADACHE, 1994, 34 (01) :35-40
[7]
THE DISTRIBUTION AND ORIGIN OF A NOVEL BRAIN PEPTIDE, NEUROPEPTIDE-Y, IN THE SPINAL-CORD OF SEVERAL MAMMALS [J].
GIBSON, SJ ;
POLAK, JM ;
ALLEN, JM ;
ADRIAN, TE ;
KELLY, JS ;
BLOOM, SR .
JOURNAL OF COMPARATIVE NEUROLOGY, 1984, 227 (01) :78-91
[8]
GIBSON SJ, 1984, PEPTIDES, V5, P201, DOI 10.1016/0196-9781(84)90207-9
[9]
HUMAN IN-VIVO EVIDENCE FOR TRIGEMINOVASCULAR ACTIVATION IN CLUSTER HEADACHE - NEUROPEPTIDE CHANGES AND EFFECTS OF ACUTE ATTACKS THERAPIES [J].
GOADSBY, PJ ;
EDVINSSON, L .
BRAIN, 1994, 117 :427-434
[10]
VASOACTIVE PEPTIDE RELEASE IN THE EXTRACEREBRAL CIRCULATION OF HUMANS DURING MIGRAINE HEADACHE [J].
GOADSBY, PJ ;
EDVINSSON, L ;
EKMAN, R .
ANNALS OF NEUROLOGY, 1990, 28 (02) :183-187